Menthol cigarette smoking in the COPDGene cohort: relationship with COPD, comorbidities and CT metrics.

PubWeight™: 0.77‹?›

🔗 View Article (PMC 4415502)

Published in Respirology on October 19, 2014

Authors

Seoung Ju Park1, Marilyn G Foreman, Dawn L Demeo, Surya P Bhatt, Nadia N Hansel, Robert A Wise, Xavier Soler, Russell P Bowler

Author Affiliations

1: Department of Medicine, National Jewish Health, Denver, Colorado, USA; Department of Internal Medicine and Research Institute of Clinical Medicine-Biomedical Research Institute of Chonbuk National University Hospital, Chonbuk National University, Jeonju, South Korea.

Articles cited by this

Genetic epidemiology of COPD (COPDGene) study design. COPD (2010) 7.67

Systemic manifestations and comorbidities of COPD. Eur Respir J (2009) 5.90

Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2008) 3.70

Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med (2000) 3.43

Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes. Radiology (2011) 3.30

Epidemiology of menthol cigarette use. Nicotine Tob Res (2004) 2.66

Systemic manifestations of COPD. Chest (2011) 2.25

Relationship between quantitative CT metrics and health status and BODE in chronic obstructive pulmonary disease. Thorax (2012) 2.15

Smoking habits and attitudes in a methadone maintenance treatment population. Drug Alcohol Depend (1997) 1.85

Menthol pharmacology and its potential impact on cigarette smoking behavior. Nicotine Tob Res (2004) 1.84

Mentholated cigarettes and smoking cessation: findings from COMMIT. Community Intervention Trial for Smoking Cessation. Tob Control (2002) 1.82

Quantitative computed tomography measures of emphysema and airway wall thickness are related to respiratory symptoms. Am J Respir Crit Care Med (2009) 1.75

Forced expiratory volume in one second: not just a lung function test but a marker of premature death from all causes. Eur Respir J (2007) 1.72

Menthol cigarettes and risk of lung cancer. Am J Epidemiol (2003) 1.43

National patterns and correlates of mentholated cigarette use in the United States. Addiction (2010) 1.41

Smoking-cessation prevalence among U.S. smokers of menthol versus non-menthol cigarettes. Am J Prev Med (2011) 1.33

Epidemiology of menthol cigarette use in the United States. Tob Induc Dis (2011) 1.32

Menthol cigarettes and health risks in Lung Health Study data. Nicotine Tob Res (2007) 1.32

Quantitative computed tomography in chronic obstructive pulmonary disease. J Thorac Imaging (2013) 1.22

Menthol cigarettes and smoking cessation behaviour: a review of tobacco industry documents. Tob Control (2011) 1.16

Automated telecommunication to obtain longitudinal follow-up in a multicenter cross-sectional COPD study. COPD (2012) 1.15

Sociocultural correlates of menthol cigarette smoking among adult African Americans in Los Angeles. Nicotine Tob Res (2007) 1.13

Possible effects on smokers of cigarette mentholation: a review of the evidence relating to key research questions. Regul Toxicol Pharmacol (2006) 1.08

Mentholated cigarettes and cardiovascular and pulmonary diseases: a population-based study. Arch Intern Med (2012) 1.04

Systematic review of the epidemiological evidence comparing lung cancer risk in smokers of mentholated and unmentholated cigarettes. BMC Pulm Med (2011) 0.96

Diagnosis of chronic obstructive pulmonary disease in lung cancer screening Computed Tomography scans: independent contribution of emphysema, air trapping and bronchial wall thickening. Respir Res (2013) 0.95

A cross-sectional study on tobacco use and dependence among women: Does menthol matter? Tob Induc Dis (2012) 0.85

Mentholated cigarettes and smoking-related cancers revisited: an ecologic examination. Regul Toxicol Pharmacol (2012) 0.81

Response of human ciliated respiratory cells to a mixture of menthol, eucalyptus oil and pine needle oil. Arzneimittelforschung (1997) 0.77

Articles by these authors

The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med (2005) 8.86

Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis (2004) 6.13

Efficacy of esomeprazole for treatment of poorly controlled asthma. N Engl J Med (2009) 5.90

Pulmonary arterial enlargement and acute exacerbations of COPD. N Engl J Med (2012) 5.54

Genomic screening and replication using the same data set in family-based association testing. Nat Genet (2005) 5.44

Randomized comparison of strategies for reducing treatment in mild persistent asthma. N Engl J Med (2007) 4.40

GOLD 2011 disease severity classification in COPDGene: a prospective cohort study. Lancet Respir Med (2012) 3.98

MMP12, lung function, and COPD in high-risk populations. N Engl J Med (2009) 3.96

Detectable clonal mosaicism from birth to old age and its relationship to cancer. Nat Genet (2012) 3.68

Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations. Nat Genet (2011) 3.68

The Gene, Environment Association Studies consortium (GENEVA): maximizing the knowledge obtained from GWAS by collaboration across studies of multiple conditions. Genet Epidemiol (2010) 3.48

Lansoprazole for children with poorly controlled asthma: a randomized controlled trial. JAMA (2012) 3.40

Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes. Radiology (2011) 3.30

The minimal important difference in the 6-minute walk test for patients with pulmonary arterial hypertension. Am J Respir Crit Care Med (2012) 3.24

Club cell protein 16 and disease progression in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2013) 2.82

Maternal vitamin A supplementation and lung function in offspring. N Engl J Med (2010) 2.61

A genome-wide association study on African-ancestry populations for asthma. J Allergy Clin Immunol (2009) 2.53

Bronchial secretory immunoglobulin a deficiency correlates with airway inflammation and progression of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2011) 2.42

Phenotypes of chronic obstructive pulmonary disease. COPD (2007) 2.33

Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline. Chest (2015) 2.32

The clinical features of the overlap between COPD and asthma. Respir Res (2011) 2.29

Cigarette smoking behaviors and time since quitting are associated with differential DNA methylation across the human genome. Hum Mol Genet (2012) 2.24

Spirometric predictors of lung function decline and mortality in early chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2012) 2.09

Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations. Am J Respir Cell Mol Biol (2005) 2.08

Mortality in patients hospitalized for asthma exacerbations in the United States. Am J Respir Crit Care Med (2006) 2.07

A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation. COPD (2012) 2.07

Early-onset chronic obstructive pulmonary disease is associated with female sex, maternal factors, and African American race in the COPDGene Study. Am J Respir Crit Care Med (2011) 2.06

Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Thorax (2007) 2.05

Six-minute walk distance in chronic obstructive pulmonary disease: reproducibility and effect of walking course layout and length. Am J Respir Crit Care Med (2003) 2.03

A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13. Hum Mol Genet (2011) 1.98

Genetic association analysis of functional impairment in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2006) 1.98

The effect of HIV infection on longitudinal lung function decline among IDUs: a prospective cohort. AIDS (2013) 1.92

Body mass index and the risk of COPD. Chest (2002) 1.91

Mapping of numerous disease-associated expression polymorphisms in primary peripheral blood CD4+ lymphocytes. Hum Mol Genet (2010) 1.89

Extracellular superoxide dismutase (EC-SOD) binds to type i collagen and protects against oxidative fragmentation. J Biol Chem (2004) 1.86

Paradoxical physical findings described by Kussmaul: pulsus paradoxus and Kussmaul's sign. Lancet (2002) 1.85

Dose-effect relationships between manganese exposure and neurological, neuropsychological and pulmonary function in confined space bridge welders. Occup Environ Med (2006) 1.81

Extracellular superoxide dismutase haplotypes are associated with acute lung injury and mortality. Am J Respir Crit Care Med (2008) 1.73

Natural history of mild-moderate pulmonary hypertension and the risk factors for severe pulmonary hypertension in scleroderma. J Rheumatol (2006) 1.73

Asthma in the elderly: Current understanding and future research needs--a report of a National Institute on Aging (NIA) workshop. J Allergy Clin Immunol (2011) 1.69

Physician and patient perceptions in COPD: the COPD Resource Network Needs Assessment Survey. Am J Med (2005) 1.67

The association of adiponectin with computed tomography phenotypes in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2013) 1.67

Gender differences of airway dimensions in anatomically matched sites on CT in smokers. COPD (2011) 1.66

Impact of co-morbidities on self-rated health in self-reported COPD: an analysis of NHANES 2001-2008. COPD (2013) 1.64

Racial differences in quality of life in patients with COPD. Chest (2011) 1.64

An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2015) 1.63

Lovastatin enhances clearance of apoptotic cells (efferocytosis) with implications for chronic obstructive pulmonary disease. J Immunol (2006) 1.62

Continuous oxygen use in nonhypoxemic emphysema patients identifies a high-risk subset of patients: retrospective analysis of the National Emphysema Treatment Trial. Chest (2008) 1.59

Gender differences in the severity of CT emphysema in COPD. Chest (2007) 1.59

Methacholine challenge test: diagnostic characteristics in asthmatic patients receiving controller medications. J Allergy Clin Immunol (2012) 1.57

Reduced Bone Density and Vertebral Fractures in Smokers. Men and COPD Patients at Increased Risk. Ann Am Thorac Soc (2015) 1.54

The IBV Valve trial: a multicenter, randomized, double-blind trial of endobronchial therapy for severe emphysema. J Bronchology Interv Pulmonol (2014) 1.51

Molecular biomarkers for quantitative and discrete COPD phenotypes. Am J Respir Cell Mol Biol (2008) 1.51

Activation-induced cell death drives profound lung CD4(+) T-cell depletion in HIV-associated chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2014) 1.50

The complex relationship of serum adiponectin to COPD outcomes COPD and adiponectin. Chest (2012) 1.50

Cluster analysis in the COPDGene study identifies subtypes of smokers with distinct patterns of airway disease and emphysema. Thorax (2014) 1.48

Feasibility of retinoids for the treatment of emphysema study. Chest (2006) 1.45

Lung Density Changes With Growth and Inflation. Chest (2015) 1.42

Association of dietary soy genistein intake with lung function and asthma control: a post-hoc analysis of patients enrolled in a prospective multicentre clinical trial. Prim Care Respir J (2012) 1.41

Sleep health in U.S. Hispanic population. Sleep (2010) 1.41

Sequelae of fume exposure in confined space welding: a neurological and neuropsychological case series. Neurotoxicology (2006) 1.36

Changes in smoking status affect women more than men: results of the Lung Health Study. Am J Epidemiol (2003) 1.33

Home indoor pollutant exposures among inner-city children with and without asthma. Environ Health Perspect (2007) 1.33

Sex differences in mortality and clinical expressions of patients with chronic obstructive pulmonary disease. The TORCH experience. Am J Respir Crit Care Med (2010) 1.33

Computed tomographic measures of pulmonary vascular morphology in smokers and their clinical implications. Am J Respir Crit Care Med (2013) 1.33

In-home particle concentrations and childhood asthma morbidity. Environ Health Perspect (2008) 1.32

Clinical research in chronic obstructive pulmonary disease: needs and opportunities. Am J Respir Crit Care Med (2003) 1.32

Testing and estimating gene-environment interactions in family-based association studies. Biometrics (2007) 1.32

Common household activities are associated with elevated particulate matter concentrations in bedrooms of inner-city Baltimore pre-school children. Environ Res (2007) 1.31

Cigarette smoke impairs clearance of apoptotic cells through oxidant-dependent activation of RhoA. Am J Respir Crit Care Med (2009) 1.31

Cross-cultural adaptation and validation of the Brazilian Portuguese version of the Neck Disability Index and Neck Pain and Disability Scale. Spine (Phila Pa 1976) (2006) 1.31

Scleroderma patients with combined pulmonary hypertension and interstitial lung disease. J Rheumatol (2003) 1.31

African Americans with asthma: genetic insights. Proc Am Thorac Soc (2007) 1.29

Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: a meta-analysis. Clin Infect Dis (2003) 1.29

Polymorphisms in IL13, total IgE, eosinophilia, and asthma exacerbations in childhood. J Allergy Clin Immunol (2007) 1.29

Phenotype harmonization and cross-study collaboration in GWAS consortia: the GENEVA experience. Genet Epidemiol (2011) 1.29

Indoor air pollution and asthma in children. Proc Am Thorac Soc (2010) 1.28

Interaction among nitric oxide, reactive oxygen species, and antioxidants during endotoxemia-related acute renal failure. Am J Physiol Renal Physiol (2003) 1.28

Effect of obesity on clinical presentation and response to treatment in asthma. J Asthma (2006) 1.26

Serum PARC/CCL-18 concentrations and health outcomes in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2011) 1.23

Racial difference in lung function in African-American and White children: effect of anthropometric, socioeconomic, nutritional, and environmental factors. Am J Epidemiol (2004) 1.23

Effect of urbanisation on asthma, allergy and airways inflammation in a developing country setting. Thorax (2011) 1.20

Allergic rhinitis and sinusitis in asthma: differential effects on symptoms and pulmonary function. Chest (2006) 1.17

Association between obstructive lung disease and markers of HIV infection in a high-risk cohort. Thorax (2011) 1.16

Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis. Ann Rheum Dis (2007) 1.15

Prediction of acute respiratory disease in current and former smokers with and without COPD. Chest (2014) 1.15

Automated telecommunication to obtain longitudinal follow-up in a multicenter cross-sectional COPD study. COPD (2012) 1.15

Mortality in COPD: causes, risk factors, and prevention. COPD (2010) 1.14

Variability of spirometry in chronic obstructive pulmonary disease: results from two clinical trials. Am J Respir Crit Care Med (2006) 1.14

Peripheral blood mononuclear cell gene expression in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol (2013) 1.12

Telomerase mutations in smokers with severe emphysema. J Clin Invest (2014) 1.11